功能性便秘的儿童目前的治疗选择-管道中有什么?
Charlotte A L Jonker1,2,3,4,5, Tirza M van Os1, Ramon R Gorter2,4,5
1Department of Pediatric Gastroenterology and Nutrition, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
功能性便秘 (FC) 在儿童中很常见,影响9.5%. 像新药和神经刺激这样的新疗法为治疗耐药病例提供了希望,最后的手段是手术.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 临床治疗学 临床治疗学
- 手术干预 手术干预
背景情况:
- 功能性便秘 (FC) 影响全球约9.5%的儿童.
- 最初的管理结合了非药理学和药理学方法.
- 显著的一小部分儿童患有耐治疗的FC.
研究的目的:
- 审查当前对儿童功能性便秘治疗的见解.
- 探索新的药理和非药理治疗选择.
- 讨论耐火病例的手术干预措施.
主要方法:
- 关于儿科功能性便秘治疗的当前文献的综述.
- 基于成年人试验数据的新型药理学药物的分析 (卢比prostone, prucalopride, linaclotide, plecanatide).
- 评估神经刺激 (后神经刺激) 和手术选择.
主要成果:
- 新型药物在增加自发性肠道排便方面表现有前途.
- 后神经刺激表现出高满意度和良好的安全性.
- 手术的选择包括注射肉毒素,抗衰退水和结肠切除.
结论:
- 儿童中耐治疗的FC是复杂的,影响生活质量.
- 个性化,逐步的方法对于管理至关重要.
- 外科干预只适用于严重的,耐火病例,作为最后的手段.
更多相关视频
03:50Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
08:24Author Spotlight: Exploring the Potential of Massage Therapy in Cerebral Palsy Using Animal Models
Published on: August 11, 2023
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Irritable Bowel Syndrome III: Medical and Nursing Management
